Enrique Poradosu Nuvectis Pharma, Inc. (NVCT) insider trading activity
Enrique Poradosu is Chief Science & Business Off of Nuvectis Pharma, Inc.. Currently has a direct ownership of 1.51 Million shares of NVCT, which is worth approximately $7.56 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 2,000 shares (Common Stock) at a price of $4.99 per share, resulting in proceeds of $9,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.51M
0.13%
3M change
9.64%
12M change
Total Value Held
$7.56 Million
Enrique Poradosu Transaction History
EP
Enrique Poradosu
Chief Science & Business Off
Fort Lee, NJ